StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Barclays Downgrades Merck (MRK) to Equalweight
October 30, 2017 2:05 AM
Barclays downgraded Merck (NYSE: MRK) from Overweight to Equalweight with a price target of $62.00 (from $72.00).Analyst Geoff Meacham cites ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Next Articles
Jefferies Upgrades Merck (MRK) to Hold
October 31, 2017 3:51 AM
Merck (MRK) PT Lowered to $67 at UBS on 'Keynote-189 Delay As Feared'
October 30, 2017 10:45 AM
Merck (MRK) PT Lowered to $64 at Bernstein
October 30, 2017 8:09 AM
Merck (MRK) PT Lowered to $69 at Leerink Partners
October 30, 2017 7:49 AM
SunTrust Robinson Humphrey Downgrades Merck (MRK) to Hold
October 30, 2017 5:26 AM
Morgan Stanley Downgrades Merck (MRK) to Equalweight
October 30, 2017 2:11 AM
Merck (MRK) Withdraws European Application for KEYTRUDA in Combination with Pemetrexed and Carboplatin for First-Line Treatment of NSCLC
October 27, 2017 4:18 PM
Merck (MRK) Tops Q3 EPS by 8c, Lifts FY EPS Gudiance
October 27, 2017 6:46 AM
